Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-26 Option Award | 2026-04-01 4:26 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Eisenberg Or Chief Financial Officer | 200,000 | $0 | 1,254,050 (Direct) | View |
Ownership | 2026-04-01 4:25 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Eisenberg Or Chief Financial Officer | 0 | $0 | 1,141,716 (Direct) | View |
Ownership | 2026-03-31 4:16 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Mandil-Levin Revital Director | 0 | $0 | 261,370 (Direct) | View |
| 2026-03-26 Option Award | 2026-03-30 5:32 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Russek-Blum Niva Chief Technology Officer | 200,000 | $0 | 467,953 (Direct) | View |
Ownership | 2026-03-30 5:31 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Russek-Blum Niva Chief Technology Officer | 0 | $0 | 303,953 (Direct) | View |
Ownership | 2026-03-30 08:51 am | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Ben-Noon Alon Chief Executive Officer 10% Owner | 0 | $0 | 4,284,233 (Direct) | View |
| 2026-03-26 Option Award | 2026-03-30 08:49 am | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Binder Hagit General Manager | 200,000 | $0 | 521,806 (Direct) | View |
Ownership | 2026-03-18 3:56 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Pellizzari Christine A Director | 0 | $0 | 279,898 (Direct) | View |
Ownership | 2026-03-18 3:36 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Tracik Ferenc Chief Medical Officer | 0 | $0 | 792,296 (Direct) | View |
Ownership | 2026-03-18 3:36 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Claiborne Cary J Director | 0 | $0 | 279,898 (Direct) | View |
Ownership | 2026-03-18 3:35 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Golan Roy Director | 0 | $0 | 160,844 (Direct) | View |
Ownership | 2026-03-18 3:35 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Leuchtenberger Mark Director | 0 | $0 | 517,951 (Direct) | View |
Ownership | 2026-03-18 3:35 pm | N/A N/A | NeuroSense Therapeutics Ltd. | NRSN | Binder Hagit General Manager | 0 | $0 | 357,806 (Direct) | View |